
Lortinib 150mg Tablet
Marketer
RPG Life Sciences Ltd
Salt Composition
Erlotinib (150mg)
Overview Lortinib 150mg Tablet
Lortinib 150mg tablets treat non-small cell lung and pancreatic cancers. Administer on an empty stomach, or one hour before or two hours after eating. Continue treatment as directed by your physician; duration depends on individual response. Follow your doctor's instructions precisely; incorrect usage or overdose can cause severe adverse reactions. Benefits may not be apparent for weeks or months; do not discontinue without medical consultation. Common side effects include nausea, vomiting, tiredness, skin rash, and weight loss. Severe diarrhea warrants increased fluid intake or medical attention. Photosensitivity necessitates sun protection. Report mouth sores, vision changes, or breathing problems immediately. Regular liver function monitoring may be recommended. Inform your healthcare provider of all other medications, as interactions are possible. Avoid use during pregnancy or breastfeeding; reliable contraception is crucial for both partners. Smoking cessation is advisable due to potential drug interactions. If taking antacids or other medications, maintain a two-hour interval from Lortinib.
Uses of Lortinib 150mg Tablet
Cancers of the pancreas and non-small-cell lung
Major Benefits of Lortinib 150mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Lortinib 150mg tablets should be administered on an empty stomach.
Common Side effects of Lortinib 150mg Tablet:
- Abdominal pain
- Bone pain
- Breathlessness
- Constipation
- Cough
- Diarrhea
- Fatigue
- Fever
- Infection
- Muscle pain
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weight loss
How to use Lortinib 150mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Lortinib 150mg Tablet on an empty stomach.
How Lortinib 150mg Tablet works:
The anti-cancer drug, Lortinib 150mg Tablet, targets lung cancer cells. These cells possess epidermal growth factor receptors (EGFRs) which regulate their proliferation. Lortinib functions by attaching to EGFR, thereby blocking the EGFR-driven cancer signaling cascades and consequently suppressing tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lortinib 150mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Lortinib 150mg tablets during pregnancy poses a confirmed risk to the fetus. Prescribing may occur exceptionally in life-threatening circumstances where potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Lortinib 150mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Lortinib 150mg Tablet on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Lortinib 150mg tablets are considered safe for individuals with kidney impairment; dosage modification is unnecessary. However, its administration is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with hepatic impairment should use Lortinib 150mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Lortinib 150mg Tablet :
Omit any missed Lortinib 150mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Lortinib 150mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
